Reported Late Tuesday, Pliant Therapeutics Announces Pricing Of Upsized $250M Public Offering Of 8,333,334 Shares Of Common Stock At A Price Of $30/Share
Pliant Therapeutics, Inc. (NASDAQ:PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the pricing of an upsized